Expressions of peroxiredoxin 1, peroxiredoxin 6 and GFAP in human brain astrocytoma and their clinical significance.
- Author:
Jinqiao ZHOU
1
;
Qiuhong LIU
;
Jingtao WANG
;
Xinbin GUO
;
Laijun SONG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Astrocytoma; metabolism; pathology; Brain Neoplasms; metabolism; pathology; Child; Child, Preschool; Female; Glial Fibrillary Acidic Protein; metabolism; Humans; Male; Middle Aged; Peroxiredoxin VI; metabolism; Peroxiredoxins; metabolism; Young Adult
- From: Journal of Southern Medical University 2012;32(9):1255-1259
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo characterize the expressions of peroxiredoxin 1 (Prx1), peroxiredoxin 6 (Prx6) and glial fibrillary acidic protein (GFAP) in human brain astrocytoma and explore their clinical significance.
METHODSThe protein and mRNA expression levels of Prx1, Prx6 and GFAP in human brain astrocytoma and normal brain tissue specimens were determined by Western blotting, RT-PCR and immunohistochemistry.
RESULTSThe protein and mRNA expressions of Prx1 and Prx6 increased significantly in the order of normal brain tissue, grade II astrocytoma, grade III astrocytoma and grade IV astrocytoma (P<0.05). The protein and mRNA expressions of GFAP decreased significantly in grade III and IV astrocytoma compared with those in grade II astrocytoma and normal brain tissues (P<0.05).
CONCLUSIONPrx1 and Prx6 may play important roles in the invasion and malignant development of human brain astrocytoma, and may serve as biomarkers for evaluating the invasiveness, malignancy and prognosis of the tumor as well as potential molecular targets in astrocytoma therapy.
